Galectin-2 induces apoptosis of lamina propria T lymphocytes and ameliorates acute and chronic experimental colitis in mice

Journal of Molecular Medicine

Volumn 86, Issue 12, 2008, Pages 1395-1406

  Paclik, Daniela ^a   Berndt, Uta ^a   Guzy, Claudia ^a   Dankof, Anja ^a   Danese, Silvio ^b   Holzloehner, Pamela ^a   Rosewicz, Stefan ^a   Wiedenmann, Bertram ^a   Wittig, Bianca M ^a   Dignass, Axel U ^a   Sturm, Andreas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Apoptosis; Galectin 2; Galectins; Inflammatory bowel diseases; T lymphocytes

Indexed keywords

DEXTRAN SULFATE; GALECTIN 2; TACROLIMUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; COLITIS; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; ENTERITIS; EXPERIMENTAL MODEL; FEMALE; FLOW CYTOMETRY; GASTROINTESTINAL TRACT; HELPER CELL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LAMINA PROPRIA; MONONUCLEAR CELL; MOUSE; NICK END LABELING; NONHUMAN; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; COLITIS; COLON; CYTOKINES; DEXTRAN SULFATE; FEMALE; GALECTIN 2; GENE EXPRESSION; MICE; MUCOUS MEMBRANE; T-LYMPHOCYTES;

EID: 56949086719     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-007-0290-2     Document Type: Article

References (50)

1. C Fiocchi 1998 Inflammatory bowel disease: etiology and pathogenesis Gastroenterology 115 182 205
2. C Fiocchi ML Hilfiker KR Youngman NC Doerder JH Finke 1984 Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease Gastroenterology 86 734 42
3. IJ Fuss M Neurath M Boirivant JS Klein MC de La SA Strong C Fiocchi W Strober 1996 Disparate CD4 + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5 J Immunol 157 1261 70
4. H Ueyama T Kiyohara N Sawada K Isozaki S Kitamura S Kondo J Miyagawa S Kanayama Y Shinomura H Ishikawa T Ohtani R Nezu S Nagata Y Matsuzawa 1998 High Fas ligand expression on lymphocytes in lesions of ulcerative colitis Gut 43 48 55
5. A Sturm AZ Leite S Danese KA Krivacic GA West S Mohr JW Jacobberger C Fiocchi 2004 Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn's disease and ulcerative colitis Gut 53 1624 31
6. K Ina J Itoh K Fukushima K Kusugami T Yamaguchi K Kyokane A Imada DG Binion A Musso GA West GM Dobrea TS McCormick EG Lapetina AD Levine CA Ottaway C Fiocchi 1999 Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance J Immunol 163 1081 90
7. T ten Hove C van Montfrans MP Peppelenbosch SJ van Deventer 2002 Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease Gut 50 206 11
8. P Rutgeerts WJ Sandborn BG Feagan W Reinisch A Olson J Johanns S Travers D Rachmilewitz SB Hanauer GR Lichtenstein WJ de Villiers D Present BE Sands JF Colombel 2005 Infliximab for induction and maintenance therapy for ulcerative colitis N Engl J Med 353 2462 76
9. BE Sands FH Anderson CN Bernstein WY Chey BG Feagan RN Fedorak MA Kamm JR Korzenik BA Lashner JE Onken D Rachmilewitz P Rutgeerts G Wild DC Wolf PA Marsters SB Travers MA Blank SJ van Deventer 2004 Infliximab maintenance therapy for fistulizing Crohn's disease N Engl J Med 350 876 85
10. GA Rabinovich LG Baum N Tinari R Paganelli C Natoli FT Liu S Iacobelli 2002 Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol 23 313 20
11. JM Ilarregui GA Bianco MA Toscano GA Rabinovich 2005 The coming of age of galectins as immunomodulatory agents: impact of these carbohydrate binding proteins in T cell physiology and chronic inflammatory disorders Ann Rheum Dis 64 Suppl 4 96 103
12. FT Liu 2000 Galectins: a new family of regulators of inflammation Clin Immunol 97 79 88
13. GA Rabinovich 1999 Galectins: an evolutionarily conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapy Cell Death Differ 6 711 21
14. A Sturm M Lensch S Andre H Kaltner B Wiedenmann S Rosewicz AU Dignass HJ Gabius 2004 Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation J Immunol 173 3825 37
15. HS Cooper SN Murthy RS Shah DJ Sedergran 1993 Clinicopathologic study of dextran sulfate sodium experimental murine colitis Lab Invest 69 238 49
16. JC Hoffmann NN Pawlowski AA Kuhl W Hohne M Zeitz 2002 Animal models of inflammatory bowel disease: an overview Pathobiology 70 121 30
17. D Rachmilewitz F Karmeli K Takabayashi T Hayashi L Leider-Trejo J Lee LM Leoni E Raz 2002 Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis Gastroenterology 122 1428 41
18. F Obermeier H Schwarz N Dunger UG Strauch N Grunwald J Scholmerich W Falk 2003 OX40/OX40L interaction induces the expression of CXCR5 and contributes to chronic colitis induced by dextran sulfate sodium in mice Eur J Immunol 33 3265 74
19. A Grabig D Paclik C Guzy A Dankof DC Baumgart J Erckenbrecht B Raupach U Sonnenborn J Eckert RR Schumann B Wiedenmann AU Dignass A Sturm 2006 Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways Infect Immun 74 4075 82
20. LA Dieleman MJ Palmen H Akol E Bloemena AS Pena SG Meuwissen EP Van Rees 1998 Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines Clin Exp Immunol 114 385 91
21. P Holzlohner U Hoffmann C Loddenkemper C Hayford K Heilmann B Wittig 2007 Antigen specific colitis abrogated by antigen feeding in a new mouse model Gastroenterology 132 A571
22. KM Murphy AB Heimberger DY Loh 1990 Induction by antigen of intrathymic apoptosis of Cd4+Cd8+Tcrlo thymocytes in vivo Science 250 1720 1723
23. C Asseman S Read F Powrie 2003 Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice: control by CD4+ regulatory T cells and IL-10 J Immunol 171 971 78
24. R Atreya J Mudter S Finotto J Mullberg T Jostock S Wirtz M Schutz B Bartsch M Holtmann C Becker D Strand J Czaja JF Schlaak HA Lehr F Autschbach G Schurmann N Nishimoto K Yoshizaki H Ito T Kishimoto PR Galle S Rose-John MF Neurath 2000 Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo Nat Med 6 583 88
25. DK Podolsky 1991 Inflammatory bowel-disease.1 N Engl J Med 325 928 37
26. SR Targan RL Deem M Liu S Wang A Nel 1995 Definition of a lamina propria T cell responsive state. Enhanced cytokine responsiveness of T cells stimulated through the CD2 pathway J Immunol 154 664 75
27. MF Neurath J Mudter 2006 Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications Gut 56 293 303
28. F Shanahan K Nally GC O'Sullivan 2000 Turning on T-cell death and turning off Crohn's disease Gastroenterology 119 1166 68
29. HJ Gabius 2006 Cell surface glycans: the why and how of their functionality as biochemical signals in lectin-mediated information transfer Crit Rev Immunol 26 43 80
30. FT Liu GA Rabinovich 2005 Galectins as modulators of tumour progression Nat Rev Cancer 5 29 41
31. J Nio Y Kon T Iwanaga 2005 Differential cellular expression of galectin family mRNAs in the epithelial cells of the mouse digestive tract J Histochem Cytochem 53 1323 34
32. L Santucci S Fiorucci N Rubinstein A Mencarelli B Palazzetti B Federici GA Rabinovich A Morelli 2003 Galectin-1 suppresses experimental colitis in mice Gastroenterology 124 1381 94
33. M Harjacek S Diaz-Cano M De Miguel H Wolfe CA Maldonado GA Rabinovich 2001 Expression of galectins-1 and -3 correlates with defective mononuclear cell apoptosis in patients with juvenile idiopathic arthritis J Rheumatol 28 1914 22
34. H Ogata T Matsui M Nakamura M Iida M Takazoe Y Suzuki T Hibi 2006 A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis Gut 55 1255 62
35. DC Baumgart JP Pintoffl A Sturm B Wiedenmann AU Dignass 2006 Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease-a long-term follow-up Am J Gastroenterol 101 1048 56
36. JM van Dieren EJ Kuipers JN Samsom EE Nieuwenhuis CJ van der Woude 2006 Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: their mechanisms of action and role in the treatment of IBD Inflamm Bowel Dis 12 311 27
37. W Strober I Fuss PJ Mannon 2007 The fundamental basis of inflammatory bowel disease J Clin Invest 117 514 21
38. J Mudter MF Neurath 2007 Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications Gut 56 293 303
39. KA Papadakis SR Targan 2000 Role of cytokines in the pathogenesis of inflammatory bowel disease Annu Rev Med 51 289 98
40. IJ Fuss C Becker Z Yang C Groden RL Hornung F Heller MF Neurath W Strober PJ Mannon 2006 Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody Inflamm Bowel Dis 12 9 15
41. J Mudter MF Neurath 2007 Il-6 signaling in inflammatory bowel disease: Pathophysiological role and clinical relevance Inflamm Bowel Dis 13 1016 23
42. H Ito M Takazoe Y Fukuda T Hibi K Kusugami A Andoh T Matsumoto T Yamamura J Azuma N Nishimoto K Yoshizaki T Shimoyama T Kishimoto 2004 A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease Gastroenterology 126 989 96
43. CT Weaver RD Hatton PR Mangan LE Harrington 2007 IL-17 family cytokines and the expanding diversity of effector T cell lineages Ann Rev Immunol 25 821 52
44. E Bettelli YJ Carrier WD Gao T Korn TB Strom M Oukka HL Weiner VK Kuchroo 2006 Reciprocal developmental pathways for the generation of pathogenic effector T(H)17 and regulatory T cells Nature 441 235 38
45. CL Langrish Y Chen WM Blumenschein J Mattson B Basham JD Sedgwick T McClanahan RA Kastelein DJ Cua 2005 IL-23 drives a pathogenic T cell population that induces autoimmune inflammation J Exp Med 201 233 40
46. CA Murphy CL Langrish Y Chen W Blumenschein T McClanahan RA Kastelein JD Sedgwick DJ Cua 2003 Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation J Exp Med 198 1951 57
47. D Yen J Cheung H Scheerens F Poulet T McClanahan B Mckenzie MA Kleinschek A Owyang J Mattson W Blumenschein E Murphy M Sathe DJ Cua RA Kastelein D Rennick 2006 IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6 J Clin Invest 116 1310 1316
48. CO Elson Y Cong CT Weaver TR Schoeb TK McClanahan RB Fick RA Kastelein 2007 Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice Gastroenterology 132 2359 70
49. PH Krammer R Arnold IN Lavrik 2007 Life and death in peripheral T cells Nat Rev Immunol 7 532 42
50. JM Van den Brande H Braat GR van den Brink HH Versteeg CA Bauer I Hoedemaeker C van Montfrans DW Hommes MP Peppelenbosch SJ van Deventer 2003 Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease Gastroenterology 124 1774 85